Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plaque Psoriasis Subjects”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01815424
What this trial is testing

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Asian Subjects With Moderate To Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 266
Large-scale testing (Phase 3)Study completedNCT03701763
What this trial is testing

Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Amgen 245
Testing effectiveness (Phase 2)Study completedNCT00521339
What this trial is testing

Apremilast Safety and PK Study in Recalcitrant Plaque Psoriasis

Who this might be right for
Psoriasis-Type PsoriasisPlaque-Type Psoriasis
Amgen 31
Testing effectiveness (Phase 2)WithdrawnNCT02993328
What this trial is testing

A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for Treatment of Plaque Psoriasis in Adults

Who this might be right for
Plaque Psoriasis
Santalis Pharmaceuticals, Inc.
Large-scale testing (Phase 3)Study completedNCT00237887
What this trial is testing

Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Abbott 1,212
Testing effectiveness (Phase 2)Study completedNCT02969018
What this trial is testing

Study To Evaluate Safety And Efficacy Of PF-06700841 In Subjects With Moderate To Severe Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Pfizer 212
Large-scale testing (Phase 3)Study completedNCT02368210
What this trial is testing

A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 306)

Who this might be right for
Plaque Psoriasis
Therapeutics, Inc. 151
Early research (Phase 1)Study completedNCT03922607
What this trial is testing

Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-157 in Healthy Volunteers and in Participants With Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
AbbVie 65
Testing effectiveness (Phase 2)UnknownNCT06170840
What this trial is testing

QY101 Ointment in Subjects With Plaque Psoriasis

Who this might be right for
Psoriasis
E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. 160
Large-scale testing (Phase 3)Study completedNCT02134210
What this trial is testing

Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)

Who this might be right for
Plaque Psoriasis
Coherus Oncology, Inc. 521
Large-scale testing (Phase 3)Study completedNCT01090427
What this trial is testing

The Safety and Efficacy of Ustekinumab in Adolescent Patients With Psoriasis (CADMUS)

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 110
Large-scale testing (Phase 3)Study completedNCT04211389
What this trial is testing

Twin Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Arcutis Biotherapeutics, Inc. 442
Large-scale testing (Phase 3)Study completedNCT00626002
What this trial is testing

Open Label Continuation Study in Moderate to Severe Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
AbbVie (prior sponsor, Abbott) 2,301
Large-scale testing (Phase 3)Ended earlyNCT01163253
What this trial is testing

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 2,867
Large-scale testing (Phase 3)Looking for participantsNCT07130604
What this trial is testing

Evaluate the Efficacy and Safety of D-2570 in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
InventisBio Co., Ltd 390
Large-scale testing (Phase 3)Study completedNCT04211363
What this trial is testing

Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Arcutis Biotherapeutics, Inc. 439
Large-scale testing (Phase 3)Study completedNCT01640951
What this trial is testing

4 Year Extension Study of Efficacy and Safety of Secukinumab in Patients With Moderate to Severe Chronic Plaque-type Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque-Type Psoriasis
Novartis Pharmaceuticals 675
Large-scale testing (Phase 3)Study completedNCT00691964
What this trial is testing

Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
AbbVie (prior sponsor, Abbott) 347
Testing effectiveness (Phase 2)Study completedNCT06542614
What this trial is testing

Treatment of Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 209
Early research (Phase 1)Study completedNCT03337022
What this trial is testing

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of CC-90006 in Subjects With Mild to Moderate Plaque-type Psoriasis

Who this might be right for
Psoriasis
Celgene 34
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation